- 1. Boenjamin Setiawan10 januari 2013
2. 1. Pada jaman Jepang thn 1944 saya dan Adik saya karmila
duduk dikelas 2 SD, sekolah Tionghoa. Sewaktu ujian Tinghsieh saya
mendapatkan angka 5 dan karmila 8. Saya dipanggil depan kelas dan
dbikin malu sama gurunya. Sejak itu saya selalu ingin menjadi nomer
satu.2. Sewaktu di FKUI saya menjadi asisten di Bgn Farmakologi dan
thn 1958 dpt beasiswa utk belajar di UCSF dan berhasil mendapatkan
gelar PhD pada tahun 1961. Suasana demokrasi di USA sangat
mempengaruhi hidup saya.3. Sekembali saya pd 1961 maka saya ingin
terus melakukan penelitian tetapi keadaan TIDAK kondusif karena
tidak ada dananya. Saya pd waktu itu tahun 1962 datang pada Pak Wim
Kalona (pemilik dan direktur DUPA) minta dana R&D untuk skrin
tanaman obat. Yang mengesankan saya adalah bahwa dia TIDAK banyak
tanya dan langsung memberikan dana yang diminta (sekitar 30 juta Rp
uang sekarang). Hal ini yang kemudian MEMICU SAYA untuk juga ingin
mendirikan PABRIK FARMASI. Saya bersama teman dokter muda Bgn
Biologi thn 1963 berusaha mendirikan pabrik farmasi ttpi gagal.
Kmdn thn 1964 sekali lagi bersama dr Yan Tan dan Kwa pemilik apotik
Usada sekali lagi berusaha ttpi juga gagal.4. Sewaktu saya mewakili
rapat Kpl Bgn di FKUI thn 1963, ditawarkan untuk kunjungan ilmiah
ke RRC saya menerima dan berangkat ke Beijing dan Pyongyang. Karena
keberangkatan ini maka saya pd Oktober tahun 1965 sewaktu Gestok
disekors selama 1 tahun. Karena banyak waktu maka saya bikin
bermacam obat bersama adik saya FBA.5. Karena disekors maka dr Kho
Tjok Khing menawarkan kpd saya untuk bekerja di Enzypharm Holland.
Sewaktu sdh mau berangkat Kakak saya drg Setiady KEBETULAN mampir
dan menanyakan mau kemana? Kmdn dia usulkan untuk bersama
mendirikan usaha Farmasi. Dgn demikina maka pada achirnya karena
LIMA KEBETULALN INI kalbe farma didirikan pada 10 September 1966.
3. 1. The Trigger that started Kalbe Farma, 1963-19662. Key Success
Factors, 1966-19773. Diversification period, 1977-19944.
Consolidation and Pre-crisis, 1995- 20005. Crisis and Survival,
2001-20076. Act Local, Go Regional and Think Global, 2007-2015Kalbe
Farma dan Technopreneurship dr.Boenjamin Setiawan, PhD., July
14,2010, UMN 3 4. A meeting with Drs Wim Kalona in 1962
(Owner-Director of P.T.DUPA) to apply for a Research Grantamounting
to about 30 million Rp. todays worth,triggered the idea to start a
pharmaceutical company In 1963, first trial to start a company
calledFARMINDO, with colleagues from the BIOLOGY Dept.but survived
only for 3 months In 1964, tried a second time with dr.Jan
Tan(Pharmacologist) and Kwa (business man), butsurvived only a few
months In 1966 with the help of my brothers and sisters, atlast, we
succeeded to form Kalbe FarmaKalbe Farma dan Technopreneurship
dr.Boenjamin Setiawan, PhD., July 14,2010, UMN 4 5. Founded at
September 10th, 1966. Started its operation in a modest garage
atJalan Simpang I No. 1, Tanjung Priok.Kalbe Farma dan
Technopreneurship dr.Boenjamin Setiawan, PhD., July 14,2010, UMN 5
6. TheFounders were driven by a keen desireto take part in the
national development,particularly in promoting the welfare ofpeople
through medical care. Motto : The Scientific Pursuit of Healthfor a
Better Life. Within a short time the Company was ableto win a fair
market share and opened tworepresentatives offices in Bandung
andSurabaya in 1969.Kalbe Farma dan Technopreneurship dr.Boenjamin
Setiawan, PhD., July 14,2010, UMN 6 7. Distribution Network
developed so fast that by1974 the whole Country was practically
covered. The Company moved from the old premises toJalan Jendral A.
Yani (Pulomas) and later on toCikarang. Kalbe Farma dan
Technopreneurship dr.Boenjamin Setiawan, PhD., July 14, 2010, UMN 7
8. In 1977 within 11 years, the Company was able to become the
largest pharmaceutical company in Indonesia (IMS report). In 1991
the Company became a public company and was listed on the Jakarta
Stock Exchange and Surabaya Stock Exchange. Now in 2012 we have
over 16,000 employees and a marketing and sales force of 6,000
covering 80% of the Indonesian consumer health and 100% of the
Indonesian prescription pharmaceutical market.Kalbe Farma dan
Technopreneurship dr.Boenjamin Setiawan, PhD., July 14,2010, UMN 8
9. 1. The RIGHT time, because in 1966 the Suharto Gov. opened the
doors for foreign investment.2. The RIGHT products and RIGHT
pricing, because as a pharmacologist and practising physican I knew
the needs of doctors3. The RIGHT marketing strategy, following the
footsteps of the foreign companies by promotion through Medical
Reps.4. The RIGHT company strategy by Professionalizing our team
from the beginning5. The RIGHT and BRIGHT people to run the company
Kalbe Farma dan Technopreneurship dr.Boenjamin Setiawan, PhD., July
14, 2010, UMN 9 10. Falsafah perusahaan merupakan dasar existensi
dan sudahmencakup visi dan misi perusahaanFalsafah Kalbe Farma
adalah sebagai berikut:1. Tujuan perusahaan adalah Survival through
Continuous , Sustainable Growth and Adaptation2. Perusahaan harus
mampu terus survive untuk para stakeholders3. Perusahaan mampu
survive karena Kwalitas SDM nya harus DJITU, C10, PBFWUSI4. Terus
mampu mengembangkan dan me-manfaatkan IPTEK5. Menganut strategi
Participative InnovativeManagementKalbe Farma dan Technopreneurship
dr.Boenjamin Setiawan, PhD., July 14,2010, UMN 10 11. Provide a
wide range of innovativepharmaceutical and health food products.
Large network of marketing, promotionand distribution teams. Cover
segments from lowest to upperclass level of society. Develop
strategic alliances with world- wide partners.Profesionalization
since the early stagesKalbe Farma dan Technopreneurship
dr.Boenjamin Setiawan, PhD., July 14,2010, UMN 11 12. 1. KWALITAS
Pimpinan dan Karyawan2. Yang paling penting IQ, EQ, SQ, SQ, LQ,
PQ3. Manusia DJITU4. Manusia 5A5. Manusia 10 C6. Manusia PBFWUSSI7.
Strategi5C8. Strategi5SContoh: ASTRA, Microsoft, Roche, Ford ,
Pfizer, Wallmart, Toyota, Apple, etc.Kalbe Farma dan
Technopreneurship dr.Boenjamin Setiawan, PhD., July 14,2010, UMN 12
13. 1. D = DISIPLIN dan DEDIKASI2. J = JUJUR dan JELI3. I =
INOVATIF dan INISIATIF4. T = TULUS dan TANGGUNG JAWAB Kalbe Farma
dan Technopreneurship dr.Boenjamin Setiawan, PhD., July 14,5. U =
ULET dan UNGGUL 2010, UMN 13 14. 1. ADAPT, adaptasi dgn
lingkungan2. ADOPT, menyesuaikan dan mengambil alih kebiasaan
lingkungan dan budaya3. ALIGN, membentuk barisan yang solid4.
AGREE, menyetujui secara mendalam5. ACTION, semuanya harus menjurus
kesuatu TUJUAN yang harus dicapai secara terintegrasi. 15. 1. 4 C =
CARE, CAPABLE, COURAGEOUS and CREATIVE2. 3 COM= COMMITTED, COMMON-
SENSE and COMMUNICATIVE,3. 3 CON= CONNECTIVITY, CONFIDENT and
CONSISTENT Kalbe Farma dan Technopreneurship dr.Boenjamin Setiawan,
PhD., July 14, 2010, UMN 15 16. 1. PROACTIVE2. Begin With the END
in MIND3. First Things First (Prioritize)4. WIN-WIN5. Understand to
be Understood6. SYNERGIZE7. Sharpen the Saw8. Inspire your Workers
and CustomersKalbe Farma dan Technopreneurship dr.Boenjamin
Setiawan, PhD., July 14,2010, UMN 16 17. 1. Company: SWOT your
company2. Customer: know and define your customers3. Competitors:
identify and know your competitors4. Country: understand the
political and social conditions of your country5. Currency: always
borrow in your countrys currency Kalbe Farma dan Technopreneurship
dr.Boenjamin Setiawan, PhD., July 14, 2010, UMN 17 18. To achieve
SPEED1. You must be SMART2. You must SIMPLIFY3. Create a SYSTEM4.
Create a SUITABLE5. SOLID Team Kalbe Farma dan Technopreneurship
dr.Boenjamin Setiawan, PhD., July 14, 2010, UMN 18 19. Kalbe Farma
dan Technopreneurship dr.Boenjamin Setiawan, PhD., July 14,2010,
UMN 19 20. Kalbe was established in 1966 and has a long track
record of sustainable growth Inception and EntrepreneurialEnhanced
Focus and Consolidation Globalization Driven Expansion19962005
20062015 19661995 1966 1977 1981 1985 1989 1991 1993 19941996 1997
2005 620062007 20091985:1989:1991: 1994: 2005: 2007: 1966:
1977:AcquirKalbeLaunch of new corporate logo as part Igar Entered
Consolidation of of transformation process Company Dankos ed Jaya
Farma energy 1996:Kalbe Group Products enter every ASEAN countries
founded LabBintan andIPO drink1997: (except Laos) Disposed Opening
of the Stem Cell and Cancerg business of 50% of Disposed of Danko
KalbesInstituteToedjoEPM IPO Implementation of end-to-end supply s
IPOs1993: foodremaining 50%chain managemente&Integrate
information technologyHexphAcquired businessownership in
PTsystemsarm Sanghiang(PT Bukit Bukit Manikam2006:
1981:PerkasaManikamExpand regional footprint Spin-off theSakti to
Arnotts Build global brands andandSakti) to Disposed glass
infrastructure distribution consolidat ArnottsScale through mergers
and business to packagingacquisitions 1000ed division toProprietary
drug development10000 PT Enseval nutritional Global partnerships
and networks due toSchottbusiness Acquired Woods800governmento8000
t regulationPeppermintSanghiang(USD mm) brand (IDR bn)600 Perkasa
6000 Acquired 80% of400Saka Farma 4000200 20000 01991 1992 1993
1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
2007 2008 2009 sales USD Sales IDR Kalbe Farma dan
Technopreneurship20 dr.Boenjamin Setiawan, PhD., July 14, 2010,
UMN20 21. Business strategy is ... the group of dynamic,
integrateddecisions that position the business inits competitive
environmentR&D StrategyMarketing Strategy (5P) Basic and
applied Product/market definition Pricingresearch
Product/processObjectives Distribution/Placementinnovation1. Growth
Promotion Lead or follow2. Profitability Customer
support/PeopleProduction3. Diversification StrategyFinancial4.
Innovation Legal Strategy Strategy Intellectual property
Facilities5. Market share Integration Capital structure protection
Cash flow6. Working Corporate Capacity Quality environment
Production7. Corporatetechnology citizenship Operations control
People management Kalbe Farma dan Technopreneurship dr.Boenjamin
Setiawan, PhD., July 14, 2010, UMN 21 22. Kalbe Farma dan
Technopreneurship dr.Boenjamin Setiawan, PhD., July 14, 22 23. D =
DEDIKASI dan DISIPLINI = INTEGRITYP = PELUANGE = EXCELLENCER =
RISIKOI = INNOVATIFK = KERJA KERASS = SIGAPA = ACTIONKalbe Farma
dan Technopreneurship dr.Boenjamin Setiawan, PhD., July 14,2010,
UMN 23 24. Green On the go EnvironmenlifestylePrevention t&
NaturalAgingManagement Theranostics Value for Growth
inmoneySocialNetworkingYoungpopulationour mostpotential market 25.
Nano Capsules forDNA Testpack Nano Medicines Endoscopies Stem Cell
ProteomicPersonalizedHealthcare Nano TechnologyBiotechnologyBlood
GlucoseMeter Medicine Intake Reminder WiMax Stem Cell Technology
forRemote DiagnosticMolecular Regeneration andBeautyGenomic Scan
toand Wellness Support TechnologyImprove Baby Quality 26. Income
Shift 2004 2030Source: Berita Resmi Statistik No. 45/07/Th. XIII, 1
Juli 2010, BPS 27. Total Expenditure on Health as % of GDP
Indonesia2.5 2.5Philippines 3.2 2.0Malaysia4.2China 4.7 1.5India
5.0 1.0Vietnam 6.0 1996 1997 1998 1999 2000 2001 2002 2003 2004
2005 2006- 1.0 2.0 3.0 4.0 5.0 6.07.0Source: WHO National Health
Accounts database, SeptemberSource: The World Bank2008 5% from
Indonesia APBN for Health Budget SJSN 28. 28 BSG Strategic Intent
WBAWIWe are an Innovative Health Care Businessproviding Health Care
Products & Its RelatedServices MissionTo improve health for a
better lifeTo be the best Indonesian Health Care company
Visiondriven by innovation, strong brands and
excellentmanagement1.Sustainable Growth Strategy2.Innovation3.World
Class Competence & Organization Values We believe in :Trust,
Mindfulness, Innovation, Strive to be thebest, Interconnectedness
29. Strategic InitiativesStrategy 30. Corporate FA, Tax &
Treasury Financial assumption for budget 2013 Inflation 6.5% GDP
Growth6% Exchange Rate (End Dec2010: 9,000)9,000 Interest rate for
Time Deposit Gross (IDR) 7% Interest rate for Time Deposit Gross
(USD) 2% Interest rate for Bank Loans (IDR)10% Interest rate for
Bank Loans (USD)7% RM Price Index1.02 31. Corporate FA, Tax &
Treasury1. FINANCE & ACCOUNTING FUNCTION a) Reporting &
Analysis. Ensureclarity, simplicity, transparency, accountability
andcompliance to standard / policies. Financial Report &
Analysis in accordance with standardformat and time schedule
defined by Corp FA. Reportsconsist of : Standard Financial Reports
(BS, PL, CF) Executive Summary, highlight & analysis of
financialKPI and key aspects to supportbusiness/management
performance Other financial information to support decisionmaking.
Comply with Relevant Generally Accepted AccountingStandard, IFRS
2012 and other regulation issued by otherregulatory bodies such as
BAPEPAM, Directorate General 32. Corporate FA, Tax & Treasury
1. FINANCE & ACCOUNTING FUNCTION (Cont) Audited Financial
Report Financial reports should be audited by external auditors
appointed by Corp FA and completed in accordance with the agreed
audit time table. Submit original audited Year-End Financial
Reports for documentation purpose and copy of Management Letter
issued by External Auditor to get insight where Corp FA could
assist in area of improvement 33. Corporate FA, Tax & Treasury
1. FINANCE & ACCOUNTING FUNCTION (Cont) b) System &
Procedure To improve efficiency in administration process and
effectiveness in finance administration control, Companies should :
Have Finance and Accounting SOP Manual which sets outall
implemented Finance and Accounting system &procedures. Comply
with general guidance provided by Corp FA(example: COA). Implement
proper documentation and filing system ineach SBU/company (refer to
Tax Regulation) 34. PEMAPARAN PROF. DR. BOEDIONO FAKULTAS EKONOMI
UNIVERSITAS INDONESIA JAKARTA, 14 SEPTEMBER 2009 35. Sumbu
KiriSumbu Kanan12% yoyLeft Hand Scale Right Hand Scale% yoyIndia139
ChinaIndonesia Vietnam96 Malaysia53 Korea 10 Japan -3 -3 Thailand-7
-6 -9 Singapore-11Taiwan2005 Source:Bloomberg 20062007200820062007
2008 2009-12-15Sumber:2005Bloomberg 200620072008 35 2005 2006
20082009 36. 36Penguatan daya saing terletak pada pembangunan
infrastruktur:1. Pembangunan infrastruktur fisik, terutama yang
dapat menurunkan biaya transport dan biaya logistik di dalam
negeri.2. Pembangunan infrastruktur lunak: Aturan Main : Agar
kegiatan ekonomi baik dari sisi produksi maupun pergerakanbarang
dan jasa dapat berlangsung dengan biaya transaksi minimum.
Birokrasi : Reformasi untuk mengurangi hambatan dan ekonomi biaya
tinggi.3. Pembangunan infrastruktur sosial Perekonomian akan lebih
tahan krisis jika terdapat sistem jaring pengaman sosialyang
memproteksi keluarga miskin sekaligus menciptakan kohesi sosial.4.
Pentingnya kreativitas 37. More Connected WorldSmarter and More
Cheaper transportationDemanding Consumercost Feel cool if spend
cheaplyTechnology Revolution Real Time Media OutsourcingCheaper
communication cost Productivity IncreaseHypercompetitionMerger and
Acquisition Internet Based Pricing Massive Over-Capacity
Globalization and cheap revolution has been speed up by the
economiccrisis43 38. Indonesia DemographicIndonesia most ACTIVE age
group (20-39) will continue to grow and will be a dominantage group
with 31% of total population (almost 90 million people) within the
next 10years.80+ 75-79 70-74 65-69 60-64 55-59 50-54 45-49 40-44
35-39 30-34 25-29 20-24 15-19 10-14 5-9 0-414,000 12,000 10,000
8,000 6,000 4,000 2,000-- 2,000 4,000 6,0008,000 10,000
12,00014,000 ThousandsThousands Male-2000 Male 2020Female-2000
Female 2020 Indonesia SEC (Nielsen 2006) A 9% B 10% C&D 65% E
16% 44 39. Three Generic Strategy1. Operational Excellence or Cost
Leadership Provide middle-of-the market products at the best price
withthe least inconvenience low price and hassle-free service.
Standardized assets and efficient operating procedures. Strong team
player. Highly automated systems, including related databases
andapplications. Deliver superior basic service by:o Making
hassle-free basic service as a key part of their value.o Support
efficient, zero-defect service.o Effectively exploited information
technology to redesign basicservice tasks. The goal is to achieve
growth. 45 40. Airlines Telecommunication Electronics46 41.
ThreeGeneric Strategy 2. Product Leadership Concentrate on offering
products that push performanceboundaries continue to innovate year
after year, product cycleafter product cycle Driven by the talents
of key individuals who developed andmarketed breakthrough. Manage a
portfolio of development activities concentrateresources on the
opportunities with the greatest potential to hitbig. Employ
structure and process:o Keep people on track by organizing the work
in a series of well-paced challenges, each with a clearly defined
outcome and tightdeadline.o Create business structures that dont
oppress.o Stress procedure where it pays the biggest dividend. 47
42. ThreeGeneric Strategy3. Customer Intimacy Focus on delivering
not what the market wants butwhat specific consumers want.As a
service company, we need to focus on Customer Service &
Customer Relation PROVIDE SOLUTIONS TO CUSTOMER NEEDS48 43. Focus
on delivering what specific consumers want, notwhat the market
wants Do not pursue one-time transactions, but
cultivaterelationships Specialize in satisfying unique needs, which
can only berecognized by virtue of close relationship and
intimateknowledge of the customer Proposition to the customer: We
have the best solution for you We provide all the support you need
to achieve optimumresults and/or value from whatever products you
buy We have to do better and better for our49 44. The operating
model of customer intimacy: Deep customer knowledge and insights
about the clients understanding process. Produce unmatched value
for clients who dont necessarily want the very latest product, but
just the best result and help in obtaining it. The business depends
on a stream of products that represent evolutionary improvement,
not evolutionary change. The management of people: The employees
are adaptable, flexible and multitalented, allowing them to
delivery reasonable responses; a mixture of seasoned and inventive
people. Hollow delivery system: The strength lies not in what we
own, but in what we know and how we coordinate expertise to deliver
solutions. 50 45. Creating deep relationships: A steady client is a
lasting assets; a one-time client is a poor investment. Deepen and
broaden areas of client support to deepen the relationship.
Exploiting the value leadership advantage: Search for new areas of
mutual cooperation, new untapped potential within the client
organization. Solution To offer clients:o Expertise that drives
client performance.o A willingness to share in clients risks.o
Real, meaningful tailoring and customization of productsand
services, not useless value-added service.51 46. Performance PT.
Aquasolve Sanaria 2006 - 2008 1.4E+10 1.2E+10 1.0E+10 8.0E+09
6.0E+09Rp. 4.0E+09 2.0E+09 0.0E+00 -2.0E+09 -4.0E+09 -6.0E+09
20062007 2008Penjualan4,331,585,5888,561,938,000
12,550,952,000Gross Margin 2,280,492,6295,349,178,000
7,342,957,000PBT(3,732,250,033) 548,843,000 804,406,000 Tahun
Penjualan Gross Margin PBT 47. Take Home Points Innovation is Key
to Growing and Maintaining aCountrys Competitive Position in the
Global Economyand to address Global Challenges Collaboration is
Essential for Innovation as Smalland Large Businesses,
Universities, and ResearchInstitutes Contribute to Regional Growth
and JobCreation New Institutions and New Incentives,
areincreasingly important to foster innovation andcollaboration
Create more ENTREPRENEURS, with high IQ, EQ, SQ, SQ, PQ and LQ
FUNDS for R&D must be INCREASEDKalbe Farma dan
Technopreneurship dr.Boenjamin Setiawan, PhD., July14, 2010, UMN 53
48. 1. Indonesia must move from a Resource Based to a KNOWLEDGE
Based Economy2. Innovation, New Ideas, New Products, New Markets,
and New Strategies are the Growth Drivers of companies3. Investment
in R&D increases share value of companies, especially
Pharmaceutical Companies4. People with Entrepreneurial talent,
Smart, high Integrity and Creativity is the Key to Improved
Prosperity5. Only Companies and community based active
organizations can Create Wealth. Governments must create a
conducive environment for business6. A close Collaboration between
Industries, Academic Institutions and the Government (ABCG) is
essential to improve PROSPERITYKalbe Farma dan Technopreneurship
dr.Boenjamin Setiawan, PhD., July14, 2010, UMN 54 49. Thank You5.-
Live with the 3 Es:Energy, Enthusiasm and Empathy.
